Stay updated on Durvalumab in Resectable Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Durvalumab in Resectable Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab in Resectable Lung Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.3.2, replacing the previous v3.3.1.
    Difference
    0.1%
    Check dated 2025-12-01T16:00:07.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.3.1 was released. The record now includes new sections such as Outcome Measures, Adverse Events, Baseline Characteristics, and Participant Flow, and notes that Quality Control review has not concluded as of 2025-11-17.
    Difference
    0.9%
    Check dated 2025-11-24T11:07:40.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added a 'Results Submitted' status to the study record and removed the 'No Results Posted' notice as well as the government funding lapse notice.
    Difference
    0.4%
    Check dated 2025-11-17T06:08:00.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The Record History for NCT03800134 shows many version updates, with recurring changes to Study Status, Contacts/Locations, and IPDSharing, reflecting ongoing adjustments to trial status and participating sites. These updates affect current participation information and how to contact researchers.
    Difference
    0.1%
    Check dated 2025-11-03T00:44:58.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    - Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.
    Difference
    9%
    Check dated 2025-10-05T06:28:50.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.
    Difference
    0.2%
    Check dated 2025-09-28T02:50:36.000Z thumbnail image

Stay in the know with updates to Durvalumab in Resectable Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab in Resectable Lung Cancer Clinical Trial page.